Evidence map›Paper›PMID 38571684›Full record

ArticleEuropean journal of breast health2024

Predictors of Unilateral Arm Lymphedema in Non-obese Locoregionally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy, Modified Radical Mastectomy, and Postoperative Irradiation.

Surjeet Dwivedi, Amiy Arnav, Varun Kumar Agarwal, S K Deshpande, Rohit Sharma, Naresh Saidha

Open access · diamondAbstract read
In one paragraph

Article in European journal of breast health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Surjeet DwivediDepartment of Surgical Oncology, Command Hospital Air Force, Bengaluru, India.ORCID https://orcid.org/0000-0001-6595-0718
Amiy ArnavDepartment of Surgical Oncology, All India Institute of Medical Sciences (AIIMS), Deoghar, India.ORCID https://orcid.org/0000-0002-8844-5121
Varun Kumar AgarwalDepartment of Surgical Oncology, Sarojini Naidu Medical College (SNMC), Agra, India.ORCID https://orcid.org/0000-0003-3164-2746
S K DeshpandeDepartment of Surgery, Command Hospital Air Force, Bengaluru, India.ORCID https://orcid.org/0009-0003-0503-2992
Rohit SharmaDepartment of Surgical Oncology, Indian Naval Hospital Ship (INHS) Kalyani, Vizag, India.ORCID https://orcid.org/0000-0002-4779-6136
Naresh SaidhaDepartment of Surgical Oncology, Command Hospital Air Force, Bengaluru, India.ORCID https://orcid.org/0000-0002-5514-3901
Command Hospital Air Force · INAll India Institute of Medical Sciences, Deoghar · INIndian Navy · INSarojini Naidu Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The most dreaded long-term complication of axillary lymph node dissection remains upper arm lymphedema. Our study has strategized the three most common identified causes of post treatment arm lymphedema, i.e., obesity, radiation, and neoadjuvant chemotherapy and tried to identify the histopathological and clinical or surgical factors which can predict arm lymphedema. Materials and Methods: This is a prospective observational study was conducted at a tertiary care referral centre in India, with strict inclusion criteria of BMI <30 kg/m Results: Total of 70 patients were included in the study. The mean age of the patients was 50.3 years (±12.9). lymphovascular invasion, total number of lymph nodes removed from level III, total number of days drain was left in situ and maximum drain output were found to be significantly (p<0.05) associated with arm lymphedema. Conclusion: In patients undergoing modified radical mastectomy with level III dissection, and postoperative irradiation, the incidence of unilateral arm lymphedema is significantly influenced by several clinicopathological factors like the total number of lymph nodes removed in level III, higher maximal drain output, prolonged duration of drain placement and the presence of lymphovascular invasion.

Indexed as

Axillary lymph node dissectionbreast cancerlocoregional therapymodified radical mastectomyneoadjuvant chemotherapyupper arm lymphedema

Identifiers

PMID38571684
PMCPMC10985571
OpenAlexW4393223174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.